GENERAL AND GOING CONCERN (Details Narrative) - USD ($)		1 Months Ended		3 Months Ended
	Aug. 31, 2023	Oct. 31, 2024	Sep. 30, 2024	Oct. 31, 2024	Oct. 31, 2023	Jul. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Accumulated deficit		$ 91,245,872		$ 91,245,872		$ 85,443,697
Cash flows from operating activities				6,955,076	$ 7,605,245
Aggregate gross proceeds		$ 5,000,000.0	$ 8,500,000	$ 11,667,001
Common stock, shares issued		36,183,161		36,183,161		18,284,661
Common stock, shares outstanding		36,183,161		36,183,161		18,284,661
Services Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Monthly fees	$ 20,000
Bria Pro Therapeutics Corp [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Percentage of shares issued and outstanding		66.60%		66.60%
Common stock, shares issued		47,945,178		47,945,178
Common stock, shares outstanding		47,945,178		47,945,178
Common shares owned		31,963,452		31,963,452